Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global generic drug market expected to reach USD 380.60 billion by 2021, growing at a CAGR of 10.8 % between 2016 and 2021.

06-Oct-2016 | Number of pages: 110 | Report Code: ZMR-212 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the generic drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the generic drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the generic drug market on a global level.

This report offers comprehensive coverage on global generic drug market along with, market trends, drivers, and restraints of the generic drug market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the generic drug market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the generic drug market by segmenting the market based on brand, therapeutic and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The brand based market covered under this study includes pure generic drugs and branded generic drugs. The therapeutic application based market covered under this study includes central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Key operating players for generic drugs market are Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt Ltd, Actavis Pharmaceuticals and Sun Pharmaceuticals.

This report segments the generic drugs market as follows:

Generic Drugs Market: Brand Segment Analysis

  • Pure generic drugs
  • Branded generic drugs

Generic Drugs Market: Therapeutic Application Segment Analysis

  • Central nervous system (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others.

Generic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Upper Respiratory Tract Treatment Infection Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1720 | Report Format:

Global Upper Respiratory Tract Treatment Infection Market: Overview One of the most common reasons for the people visiting the clinics and hospitals is upper respiratory tract infection. A contagious and acute infection that occurs in the upper respiratory tract is known as upper respiratory tra...Read More

Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1712 | Report Format:

Global Sickle Cell Anemia Treatment Market: Overview A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal cond...Read More

Tuberculosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1702 | Report Format:

Global Tuberculosis Therapeutics Market: Overview Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the...Read More

Systemic Infection Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1701 | Report Format:

Global Systemic Infection Treatment Market: Overview Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the persons bloodstream and gradually spreads to the whole body. The syst...Read More

Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1694 | Report Format:

Global Empty Capsules Market: Overview Empty capsules allow users to fill colorants, bulking agents, and fillers on their own in the capsule. It also permits the user to mix different ingredients together and accordingly decide the specifications of the capsules. Empty capsules are safe, cheaper...Read More

Choose License Type: